Servier Egypt launches Tibsovo as first targeted therapy for IDH1-mutated cancers
Servier Egypt has launched Tibsovo (ivosidenib), the first targeted therapy available in…
Tag: AML
Servier Egypt has launched Tibsovo (ivosidenib), the first targeted therapy available in…